Document is current
Any future updates will be listed below
-
Authors
Lei, Miao
Jingjing, Zhao
Tao, Jia
Jianping, Mao
Yuanxin, Zhu
Jifeng, Wei
Lianguo, Xue
Lidong, Zhao
Ying, Wang
- License Information
-
More Information
Article History
Received: 24 August 2019
Accepted: 3 December 2019
First Online: 14 December 2019
Compliance with ethical standards
:
: The authors declare that they have no conflict of interest.
: Patients were diagnosed according to the criteria of the World Health Organization classification of hematological malignancies. Before the initiation of treatment, the clinical features, including Mantle Cell Lymphoma International Prognostic Index (MIPI) score, lactate dehydrogenase (LDH) content in serum, performance status (determined using Eastern Cooperative Oncology Group performance status scores), and white blood cell (WBC) counts, were collected. All experimental protocols and procedures involved in the present study were approved by the Ethics Committee of the First People’s Hospital of Lianyungang. Written informed consent was obtained from all participates for publication of this article.
